Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study

BMC Infectious Diseases

Michael Z. David²  Ethan Silverman¹  Moira McNulty¹  Vagish Hemmige³ 

[1]Department of Medicine, University of Chicago, 5841 S Maryland, Chicago 60637, IL, USA

[2]Department of Pediatrics and Department of Public Health Sciences, University of Chicago, 5841 S. Maryland Ave. MC6054, Chicago 60637, IL, USA

[3]Division of Infectious Diseases, Department of Medicine, Baylor College of Medicine, 6620 Main, Suite 1375, Houston 77030, TX, USA

关键词: MRSA;    Skin and soft tissue infections;    Epidemiology;    HIV;   

Others  :  1232844
DOI  :  10.1186/s12879-015-1216-1

 received in 2015-03-17, accepted in 2015-10-14,  发布年份 2015

【 摘 要 】

Background

Skin and soft tissue infections (SSTIs) are common in the era of community-associated methicillin resistant Staphylococcus aureus among HIV-infected patients. Recurrent infections are frequent. Risk factors for recurrence after an initial SSTI have not been well-studied.

Methods

Retrospective cohort study, single center, 2005–2009. Paper and electronic medical records were reviewed by one of several physicians. Subjects with initial SSTI were followed until the time of SSTI recurrence. Standard descriptive statistics were calculated to describe the characteristics of subjects who did and did not develop a recurrent SSTI. Kaplan-Meier methods were used to estimate the risk of recurrent SSTI. A Cox regression model was developed to identify predictors of SSTI recurrence.

Results

133 SSTIs occurred in 87 individuals. 85 subjects were followed after their initial SSTI, of whom 30 (35.3 %) had a recurrent SSTI in 118.3 person-years of follow-up, for an incidence of second SSTI of 253.6 SSTIs/1000 person-years (95 % CI 166.8-385.7). The 1-year Kaplan-Meier estimated risk of a second SSTI was 29.2 % (95 % CI 20.3–41.0 %), while the 3-year risk was 47.0 % (95 % CI 34.4–61.6 %). Risk factors for recurrent SSTI in a multivariable Cox regression model were non-hepatitis liver disease (HR 3.44; 95 % CI 1.02–11.5; p = 0.05), the presence of an intravenous catheter (HR 6.50; 95 % CI 1.47–28.7; p = 0.01), and a history of intravenous drug use (IVDU) (HR 2.80; 95 % CI 1.02-7.65; p = 0.05); African-American race was associated with decreased risk of recurrent SSTI (HR 0.12; 95 % CI 0.04-0.41; p < 0.01). Some evidence was present for HIV viral load ≥ 1000 copies/mL as an independent risk factor for recurrent SSTI (HR 2.21; 95 % CI 0.99-4.94; p = 0.05). Hemodialysis, currently taking HAART, CD4+ count, trimethoprim-sulfamethoxazole or azithromycin use, initial SSTI type, diabetes mellitus, incision and drainage of the original SSTI, or self-report of being a man who has sex with men were not associated with recurrence.

Conclusion

Of HIV-infected patients with an SSTI, nearly 1/3 had a recurrent SSTI within 1 year. Risk factors for recurrent SSTI were non-hepatitis liver disease, intravenous catheter presence, a history of IVDU, and non-African-American race. Low CD4+ count was not a significant risk factor for recurrence.

【 授权许可】

   
2015 Hemmige et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S et al.. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998; 279(8):593-8.
• [2]King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006; 144(5):309-17.
• [3]David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010; 23(3):616-87.
• [4]Imaz A, Pujol M, Barragan P, Dominguez MA, Tiraboschi JM, Podzamczer D. Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patients. AIDS Rev. 2010; 12(3):153-63.
• [5]Cole J, Popovich K. Impact of community-associated methicillin resistant Staphylococcus aureus on HIV-infected patients. Curr HIV/AIDS Rep. 2013; 10(3):244-53.
• [6]Hemmige V, McNulty M, Silverman E, David MZ. Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era. Eur J Clin Microbiol Infect Dis. 2015; 34(2):339-47.
• [7]Vyas K, Hospenthal DR, Mende K, Crum-Cianflone NF. Recurrent community-acquired methicillin-resistant Staphylococcus aureus infections in an HIV-infected person. J Clin Microbiol. 2011; 49(5):2047-53.
• [8]Anderson EJ, Hawkins C, Bolon MK, Palella FJ. A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. J Acquir Immune Defic Syndr. 2006; 41(1):125-7.
• [9]Graber CJ, Jacobson MA, Perdreau-Remington F, Chambers HF, Diep BA. Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr. 2008; 49(2):231-3.
• [10]Crum-Cianflone N, Weekes J, Bavaro M. Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDS. 2009; 23(7):499-502.
• [11]Vyas KJ, Shadyab AH, Lin CD, Crum-Cianflone NF. Trends and Factors Associated with Initial and Recurrent Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft-Tissue Infections among HIV-Infected Persons: An 18-Year Study. Journal of the International Association of Providers of AIDS Care. 2013. doi:10.1177/2325957412473780.
• [12]Skiest D, Brown K, Hester J, Moore T, Crosby C, Mussa HR et al.. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med. 2006; 7(6):361-8.
• [13]Cox DR. Regression models and life tables. JR Stat Soc B. 1972; 34(2):187-220.
• [14]Cox DR, Snell EJ. A general definition of residuals (with discussion). J R Stat Soc Ser B. 1968; 30:248-75.
• [15]Cleves M, Gould W, Gutierrez R, Marchenko Y. An Introduction to Survival Analysis Using Stata. 3rd ed. Stata Press, College Station, TX; 2010.
• [16]Yelland LN, Salter AB, Ryan P. Performance of the modified poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol. 2011; 174(8):984-92.
• [17]Hosmer D, Lemeshow S. Applied survival analysis: regression modeling of time to event data. Wiley, Hoboken, NJ; 2011.
• [18]Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K et al.. Health care-associated invasive MRSA infections, 2005–2008. JAMA. 2010; 304(6):641-8.
• [19]Hemmige V, McNulty M, Silverman E, David MZ. Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era. Eur J Clin Microbiol Infect Dis. 2014. doi:10.1007/s10096-014-2237-1.
• [20]Hidron AI, Kempker R, Moanna A, Rimland D. Methicillin-resistant Staphylococcus aureus in HIV-infected patients. Infection and Drug Resistance. 2010; 3:73-86.
• [21]Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS et al.. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009; 48(2):248-56.
• [22]Popovich KJ, Hota B, Aroutcheva A, Kurien L, Patel J, Lyles-Banks R et al.. Community-Associated Methicillin-Resistant Staphylococcus aureus Colonization Burden in HIV-Infected Patients. Clin Infect Dis. 2013; 56(8):1067-74.
• [23]Corredoira JM, Ariza J, Pallarés R, Carratalá J, Viladrich PF, Rufí G et al.. Gram-negative bacillary cellulitis in patients with hepatic cirrhosis. Eur J Clin Microbiol Infect Dis. 1994; 13(1):19-24.
• [24]Mathews WC, Caperna JC, Barber RE, Torriani FJ, Miller LG, May S et al.. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr. 2005; 40(2):155-60.
• [25]Lee NE, Taylor MM, Bancroft E, Ruane PJ, Morgan M, McCoy L et al.. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis. 2005; 40(10):1529-34.
• [26]Crum-Cianflone NF, Grandits G, Weintrob A, Ganesan A, Agan B, Landrum M. Skin and soft tissue infections among HIV-infected persons in the late combination antiretroviral therapy era. Int J STD AIDS. 2012; 23(7):507-11.
• [27]Giordano TP, Gifford AL, White AC, Suarez-Almazor ME, Rabeneck L, Hartman C et al.. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007; 44(11):1493-9.